Trovagene Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Trovagene Inc
TickerCRDF
CIK #0001213037
CUSIP14147L108
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address11055 Flintkote Avenue, San Diego, CA 92121
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Cardiff Oncology Inc 2020-06-23 13.5 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Trovagene Inc 2020-04-14 2.1 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001213037] 10-K
[0001213037] 10-Q
[0001213037] 3
[0001213037] 4
[0001213037] 8-K
[0001213037] D
[0001213037] SC 13D
[0001213037] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Cardiff Oncology Inc [2025-07-29] 0.0
BlackRock Inc Cardiff Oncology Inc [2025-04-23] 0.0
Commodore Capital LP Cardiff Oncology Inc [2024-12-17] 0.0
BlackRock Inc Cardiff Oncology Inc [2024-11-08] 5.9
BlackRock Inc Cardiff Oncology Inc [2024-10-24] 5.9
Acorn BioVentures LP Cardiff Oncology Inc [2023-01-26] 6.38
BlackRock Inc Cardiff Oncology Inc [2022-07-08] 1.6
BlackRock Inc Cardiff Oncology Inc [2022-02-04] 6.0
Pfizer Inc Cardiff Oncology Inc [2021-11-19] 58.0
Corriente Advisors LLC Cardiff Oncology Inc [2021-02-16] 5.66
Janus Henderson Group PLC Cardiff Oncology Inc [2021-02-12] 6.1
State Street Corp Cardiff Oncology Inc [2021-02-11] 7.22
Avidity Partners Management LP Cardiff Oncology Inc [2021-02-02] 6.1
Venrock Healthcare Capital Partners III LP Cardiff Oncology Inc [2020-11-04] 5.7
RA Capital Management LP Cardiff Oncology Inc [2020-10-09] 10.9
Opaleye Management Inc Cardiff Oncology Inc [2020-08-28] 11.0
Acorn BioVentures LP Cardiff Oncology Inc [2020-07-02] 0.99
Caxton Corp Cardiff Oncology Inc [2020-06-22] 0.9
Acorn BioVentures LP Cardiff Oncology Inc [2020-06-04] 9.99
Lincoln Park Capital Fund LLC Trovagene Inc [2019-11-04] 0.99
Armistice Capital LLC Trovagene Inc [2019-11-01] 0.99
Bigger Capital Fund L P Trovagene Inc [2018-06-18] 8.7
Ayrton Capital LLC Trovagene Inc [2018-06-15] 4.99
Intracoastal Capital LLC Trovagene Inc [2017-12-26] 4.8
CVI Investments Inc Trovagene Inc [2017-07-24] 5.7
Sabby Management LLC Trovagene Inc [2017-07-17] 5.7
Bridger Management LLC Trovagene Inc [2016-11-15] 8.0
Bridger Management LLC Trovagene Inc [2016-04-05] 11.0
Hunter Robert Merrill Trovagene Inc [2016-03-07] 4.97
BlackRock Inc Trovagene Inc [2016-01-28] 5.2
Bridger Management LLC Trovagene Inc [2013-08-09] 11.9
Sabby Management LLC Trovagene Inc [2012-08-13] 5.43
[2012-01-24] None
[2012-01-24] None
Form 3/4/5 Filer 2011 - 2026
Mohindru Mani
Cardiff Oncology Inc
Pace Gary W
Markin Rodney S
Tannenbaum Renee P
White Lale
Armitage James O
Aggarwal Ajay
Smeal Tod
Muntner Joshua B
Lindsay Brigitte Ute
Sidhu Roger
Kabbinavar Fairooz
Erlander Mark
Levine James E
Kelemen Vicki
Brancaccio John P
Ruffner Katherine L
Jacob Gary S
Adams Thomas PhD
Shah Rajeev M
RA Capital Management LP
Kolchinsky Peter
Countouriotis Athena
Tennant Stanley
Welch William J
Billings Paul
Bridger Management LLC
Mignone Roberto
Zaniboni Steve
Schuh Antonius
Posard Matthew L
Feldbaum Carl B
Cerrone Gabriel
McGuigan Christopher
Hunter Robert Merrill
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mohindru Mani
Stock Options · derivative
2026-02-17 Grant 200,000 $0.00
Lindsay Brigitte Ute
Stock Options · derivative
2026-02-13 Grant 200,000 $0.00
Pace Gary W
Common Stock
2025-07-30 Buy 15,000 $2.45 36,750
Pace Gary W
Common Stock
2025-07-30 Buy 275,000 $2.45 673,750
Armitage James O
Stock Options · derivative
2025-06-26 Grant 40,565 $0.00
White Lale
Stock Options · derivative
2025-06-26 Grant 40,565 $0.00
Pace Gary W
Stock Options · derivative
2025-06-26 Grant 40,565 $0.00
Tannenbaum Renee P
Stock Options · derivative
2025-06-26 Grant 40,565 $0.00
Markin Rodney S
Stock Options · derivative
2025-06-26 Grant 40,565 $0.00
Mohindru Mani
Stock Options · derivative
2025-06-26 Grant 40,565 $0.00
Levine James E
Stock Options · derivative
2025-03-11 Grant 332,621 $0.00
Smeal Tod
Stock Options · derivative
2025-03-11 Grant 332,621 $0.00
Erlander Mark
Stock Options · derivative
2025-03-11 Grant 758,400 $0.00
Kabbinavar Fairooz
Stock Options · derivative
2025-03-11 Grant 150,000 $0.00
Levine James E
Common Stock
2024-12-18 Buy 2,400 $5.00 12,000
Levine James E
Common Stock
2024-12-17 Buy 2,752 $5.42 14,916
Levine James E
Common Stock
2024-12-16 Buy 2,564 $3.83 9,820
Tannenbaum Renee P
Common Stock
2024-12-12 Buy 10,000 $3.42 34,200
Pace Gary W
Common Stock
2024-12-11 Buy 350,115 $2.60 910,299
Pace Gary W
Common Stock
2024-12-11 Buy 11,500 $2.60 29,900
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 116 25,145,316
2025-12-31 110 27,808,515
2025-09-30 113 26,489,123
2025-06-30 119 30,086,764
2025-03-31 120 33,352,510
2024-12-31 118 29,141,683
2024-09-30 85 13,669,665
2024-06-30 91 14,020,482
2024-03-31 79 9,533,106
2023-12-31 56 5,357,657
2023-09-30 58 5,664,558
2023-06-30 54 6,002,669
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 67,231 67,231
Curated Wealth Partners LLC [2026-06-30] OTR 0 35,000
Post Resch Tallon Group Inc [2026-06-30] SOLE 0 22,515
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 22,388 22,388
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 584 12,095
Ledgewood Wealth Advisors LLC [2026-06-30] SOLE 0 11,190
Security National Bank [2026-06-30] SOLE 9,767 9,767
Trust Co of Toledo NA /OH/ [2026-06-30] SOLE 0 9,000
IFP Advisors LLC [2026-06-30] SOLE 3,840 3,840
Farther Finance Advisors LLC [2026-06-30] SOLE 0 2,879
Fortitude Family Office LLC [2026-06-30] SOLE 379 379
Gamma Investing LLC [2026-06-30] DFND 147 147
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com